JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, H.-e.
Right arrow Articles by Tseng, L. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, H.-e.
Right arrow Articles by Tseng, L. F.

Vol. 299, Issue 3, 1120-1125, December 2001

Acute Antinociceptive Tolerance and Asymmetric Cross-Tolerance between Endomorphin-1 and Endomorphin-2 Given Intracerebroventricularly in the Mouse

Hsiang-en Wu, Kuei-chun Hung, Hirokazu Mizoguchi, James M. Fujimoto and Leon F. Tseng

Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin

Development of tolerance in mice pretreated intracerebroventricularly with µ-opioid receptor agonist endomorphin-1, endomorphin-2, or [D-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin (DAMGO) was compared between endomorphin-1- and endomorphin-2-induced antinociception with the tail-flick test. A 2-h pretreatment with endomorphin-1 (30 nmol) produced a 3-fold shift to the right in the dose-response curve for endomorphin-1. Similarly, a 1-h pretreatment with endomorphin-2 (70 nmol) caused a 3.9-fold shift to the right for endomorphin-2. In cross-tolerance experiments, pretreatment with endomorphin-2 (70 nmol) caused a 2.3-fold shift of the dose-response curve for endomorphin-1, whereas pretreatment with endomorphin-1 (30 nmol) caused no change of the endomorphin-2 dose-response curve. Thus, mice acutely tolerant to endomorphin-1 were not cross-tolerant to endomorphin-2, although mice made tolerant to endomorphin-2 were partially cross-tolerant to endomorphin-1; an asymmetric cross-tolerance occurred. Pretreatment with DAMGO 3 h before intracerebroventricular injection of endomorphin-1, endomorphin-2, or DAMGO attenuated markedly the antinociception induced by endomorphin-1 and DAMGO but not endomorphin-2. It is proposed that two separate subtypes of µ-opioid receptors are involved in antinociceptive effects induced by endomorphin-1 and endomorphin-2. One subtype of opioid µ-receptors is stimulated by DAMGO, endomorphin-1, and endomorphin-2, and another subtype of µ-opioidreceptors is stimulated solely by endomorphin-2.

0022-3565/01/2993-1120$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Pharmacol. Rev.Home page
J. Fichna, A. Janecka, J. Costentin, and J.-C. Do Rego
The Endomorphin System and Its Evolving Neurophysiological Role
Pharmacol. Rev., March 1, 2007; 59(1): 88 - 123.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Terashvili, H.-e. Wu, R. J. Leitermann, K.-c. Hung, A. D. Clithero, E. T. Schwasinger, and L. F. Tseng
Differential Conditioned Place Preference Responses to Endomorphin-1 and Endomorphin-2 Microinjected into the Posterior Nucleus Accumbens Shell and Ventral Tegmental Area in the Rat
J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 816 - 824.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H.-E. Wu, H.-S. Sun, M. Darpolar, R. J. Leitermann, J. P. Kampine, and L. F. Tseng
Dynorphinergic Mechanism Mediating Endomorphin-2-Induced Antianalgesia in the Mouse Spinal Cord
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1135 - 1141.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H.-e. Wu, H. Mizoguchi, M. Terashvili, R. J. Leitermann, K.-c. Hung, J. M. Fujimoto, and L. F. Tseng
Spinal Pretreatment with Antisense Oligodeoxynucleotides against Exon-1, -4, or -8 of {micro}-Opioid Receptor Clone Leads to Differential Loss of Spinal Endomorphin-1-and Endomorphin-2-Induced Antinociception in the Mouse
J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 867 - 873.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K.-c. Hung, H.-e. Wu, H. Mizoguchi, S. Sakurada, T. Okayama, T. Fujimura, K. Murayama, T. Sakurada, J. M. Fujimoto, and L. F. Tseng
D-Pro2-Endomorphin-1 and D-Pro2-Endomorphin-2, Respectively, Attenuate the Antinociception Induced by Endomorphin-1 and Endomorphin-2 Given Intrathecally in the Mouse
J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 874 - 879.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.